GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (STU:MMQ) » Definitions » Additional Paid-In Capital

Mind Medicine (STU:MMQ) Additional Paid-In Capital : €496.64 Mil(As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Mind Medicine Additional Paid-In Capital?


Mind Medicine's quarterly additional paid-in capital declined from Sep. 2023 (€338.76 Mil) to Dec. 2023 (€337.45 Mil) but then increased from Dec. 2023 (€337.45 Mil) to Mar. 2024 (€496.64 Mil).

Mind Medicine's annual additional paid-in capital increased from Dec. 2021 (€255.14 Mil) to Dec. 2022 (€325.45 Mil) and increased from Dec. 2022 (€325.45 Mil) to Dec. 2023 (€337.45 Mil).

Mind Medicine Additional Paid-In Capital Historical Data

The historical data trend for Mind Medicine's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mind Medicine Additional Paid-In Capital Chart

Mind Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
98.82 255.14 325.45 337.45

Mind Medicine Quarterly Data
Sep19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 325.95 326.76 338.76 337.45 496.64

Mind Medicine Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Mind Medicine Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Mind Medicine's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Mind Medicine (STU:MMQ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mind Medicine Inc (STU:MMQ) » Definitions » Additional Paid-In Capital
Comparable Companies
TSX:EPRX XCNQ:DTC TSX:ONC TSXV:NGEN TSX:BCT XCNQ:MSET TSXV:ARCH TSXV:MIR TSXV:DMT TSX:HBP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
MNMD:USA MMED:Canada
Address
One World Trade Center, Suite 8500, New York, NY, USA, 10007
Website
https://www.mindmed.co
Mind Medicine Inc is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The firm is having an approach towards developing the next generation of psychedelic inspired medicines and therapies.

Mind Medicine (STU:MMQ) Headlines

No Headlines